USA Diagnostic Radiopharmaceuticals and Contrast Media Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Diagnostic Radiopharmaceuticals and Contrast Media market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Diagnostic Radiopharmaceuticals and Contrast Media market. Detailed analysis of key players, along with key growth strategies adopted by Diagnostic Radiopharmaceuticals and Contrast Media industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Medtronic

    • Nordion

    • Bracco Imaging

    • Daiichi Sankyo

    • Mallinckrodt

    • Bayer Healthcare

    • Guerbet

    • Amag Pharmaceuticals

    • Lantheus

    • GE Healthcare

    By Type:

    • Radiopharmaceuticals

    • Contrast Media

    By End-User:

    • Diagnostic

    • Therapeutic

    • Ionizing Radiation based Radioimaging

    • Non-Ionizing Radiation based Radioimaging

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Diagnostic Radiopharmaceuticals and Contrast Media Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Radiopharmaceuticals from 2016 to 2027

      • 1.3.2 USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Contrast Media from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Diagnostic from 2016 to 2027

      • 1.4.2 USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Therapeutic from 2016 to 2027

      • 1.4.3 USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Ionizing Radiation based Radioimaging from 2016 to 2027

      • 1.4.4 USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Non-Ionizing Radiation based Radioimaging from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Diagnostic Radiopharmaceuticals and Contrast Media Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Diagnostic Radiopharmaceuticals and Contrast Media by Major Types

      • 3.4.1 Market Size and Growth Rate of Radiopharmaceuticals

      • 3.4.2 Market Size and Growth Rate of Contrast Media

    4 Segmentation of Diagnostic Radiopharmaceuticals and Contrast Media Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Diagnostic Radiopharmaceuticals and Contrast Media by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Diagnostic Radiopharmaceuticals and Contrast Media in Diagnostic

      • 4.4.2 Market Size and Growth Rate of Diagnostic Radiopharmaceuticals and Contrast Media in Therapeutic

      • 4.4.3 Market Size and Growth Rate of Diagnostic Radiopharmaceuticals and Contrast Media in Ionizing Radiation based Radioimaging

      • 4.4.4 Market Size and Growth Rate of Diagnostic Radiopharmaceuticals and Contrast Media in Non-Ionizing Radiation based Radioimaging

    5 Market Analysis by Regions

    • 5.1 USA Diagnostic Radiopharmaceuticals and Contrast Media Production Analysis by Regions

    • 5.2 USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis

    • 6.1 West USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis by Major Types

    • 6.2 West USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis by Major End-Users

    7 South USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis

    • 7.1 South USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis by Major Types

    • 7.2 South USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis by Major End-Users

    8 Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis

    • 8.1 Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis by Major Types

    • 8.2 Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis by Major End-Users

    9 Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis

    • 9.1 Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis by Major Types

    • 9.2 Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Medtronic

        • 10.1.1 Medtronic Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Nordion

        • 10.2.1 Nordion Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Bracco Imaging

        • 10.3.1 Bracco Imaging Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Daiichi Sankyo

        • 10.4.1 Daiichi Sankyo Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Mallinckrodt

        • 10.5.1 Mallinckrodt Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Bayer Healthcare

        • 10.6.1 Bayer Healthcare Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Guerbet

        • 10.7.1 Guerbet Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Amag Pharmaceuticals

        • 10.8.1 Amag Pharmaceuticals Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Lantheus

        • 10.9.1 Lantheus Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 GE Healthcare

        • 10.10.1 GE Healthcare Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Radiopharmaceuticals from 2016 to 2027

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Contrast Media from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Diagnostic from 2016 to 2027

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Therapeutic from 2016 to 2027

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Ionizing Radiation based Radioimaging from 2016 to 2027

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Growth Rate of Non-Ionizing Radiation based Radioimaging from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Diagnostic Radiopharmaceuticals and Contrast Media Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Diagnostic Radiopharmaceuticals and Contrast Media

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Diagnostic Radiopharmaceuticals and Contrast Media by Different Types from 2016 to 2027

    • Table Consumption Share of Diagnostic Radiopharmaceuticals and Contrast Media by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Radiopharmaceuticals

    • Figure Market Size and Growth Rate of Contrast Media

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Diagnostic Radiopharmaceuticals and Contrast Media by Different End-Users from 2016 to 2027

    • Table Consumption Share of Diagnostic Radiopharmaceuticals and Contrast Media by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Diagnostic

    • Figure Market Size and Growth Rate of Therapeutic

    • Figure Market Size and Growth Rate of Ionizing Radiation based Radioimaging

    • Figure Market Size and Growth Rate of Non-Ionizing Radiation based Radioimaging

    • Table USA Diagnostic Radiopharmaceuticals and Contrast Media Production by Regions

    • Table USA Diagnostic Radiopharmaceuticals and Contrast Media Production Share by Regions

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Production Share by Regions in 2016

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Production Share by Regions in 2021

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Production Share by Regions in 2027

    • Table USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Regions

    • Table USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Regions

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Regions in 2016

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Regions in 2021

    • Figure USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Regions in 2027

    • Table West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Types from 2016 to 2027

    • Table West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types from 2016 to 2027

    • Figure West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2016

    • Figure West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2021

    • Figure West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2027

    • Table West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by End-Users from 2016 to 2027

    • Table West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2016

    • Figure West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2021

    • Figure West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2027

    • Table South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Types from 2016 to 2027

    • Table South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types from 2016 to 2027

    • Figure South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2016

    • Figure South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2021

    • Figure South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2027

    • Table South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by End-Users from 2016 to 2027

    • Table South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2016

    • Figure South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2021

    • Figure South USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2027

    • Table Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Types from 2016 to 2027

    • Table Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2016

    • Figure Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2021

    • Figure Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2027

    • Table Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2016

    • Figure Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2021

    • Figure Middle West USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2027

    • Table Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Types from 2016 to 2027

    • Table Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2016

    • Figure Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2021

    • Figure Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by Types in 2027

    • Table Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2016

    • Figure Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2021

    • Figure Northeast USA Diagnostic Radiopharmaceuticals and Contrast Media Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Medtronic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic

    • Figure Sales and Growth Rate Analysis of Medtronic

    • Figure Revenue and Market Share Analysis of Medtronic

    • Table Product and Service Introduction of Medtronic

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Bayer Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare

    • Figure Sales and Growth Rate Analysis of Bayer Healthcare

    • Figure Revenue and Market Share Analysis of Bayer Healthcare

    • Table Product and Service Introduction of Bayer Healthcare

    • Table Company Profile and Development Status of Guerbet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guerbet

    • Figure Sales and Growth Rate Analysis of Guerbet

    • Figure Revenue and Market Share Analysis of Guerbet

    • Table Product and Service Introduction of Guerbet

    • Table Company Profile and Development Status of Amag Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amag Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Amag Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Amag Pharmaceuticals

    • Table Product and Service Introduction of Amag Pharmaceuticals

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.